284 related articles for article (PubMed ID: 7995960)
41. Characterization of the upstream enhancer of the rat sodium/iodide symporter gene.
Chun JT; Di Lauro R
Exp Clin Endocrinol Diabetes; 2001; 109(1):23-6. PubMed ID: 11573134
[TBL] [Abstract][Full Text] [Related]
42. Increased LFA-1-mediated homotypic cell adhesion is associated with the G1 growth arrest induced by rapamycin in a T cell lymphoma.
Dumont FJ; Fischer P; Sirotina A
Exp Cell Res; 1995 Jul; 219(1):146-58. PubMed ID: 7543051
[TBL] [Abstract][Full Text] [Related]
43. Binding specificity of cyclic adenosine 3',5'-monophosphate-responsive element (CRE)-binding proteins and activating transcription factors to naturally occurring CRE sequence variants.
Drust DS; Troccoli NM; Jameson JL
Mol Endocrinol; 1991 Oct; 5(10):1541-51. PubMed ID: 1837842
[TBL] [Abstract][Full Text] [Related]
44. Activating transcription factor-1 is a specific antagonist of the cyclic adenosine 3'.5'-monophosphate (cAMP) response element-binding protein-1-mediated response to cAMP.
Ellis MJ; Lindon AC; Flint KJ; Jones NC; Goodbourn S
Mol Endocrinol; 1995 Feb; 9(2):255-65. PubMed ID: 7776975
[TBL] [Abstract][Full Text] [Related]
45. A dominant repressor of cyclic adenosine 3',5'-monophosphate (cAMP)-regulated enhancer-binding protein activity inhibits the cAMP-mediated induction of the somatostatin promoter in vivo.
Walton KM; Rehfuss RP; Chrivia JC; Lochner JE; Goodman RH
Mol Endocrinol; 1992 Apr; 6(4):647-55. PubMed ID: 1350057
[TBL] [Abstract][Full Text] [Related]
46. Cell type-specific regulation of transcription by cyclic adenosine 3,'5'-monophosphate-responsive elements within the calcitonin promoter.
Monla YT; Peleg S; Gagel RF; Monia YT
Mol Endocrinol; 1995 Jul; 9(7):784-93. PubMed ID: 7476962
[TBL] [Abstract][Full Text] [Related]
47. A zinc-dependent DNA-binding activity co-operates with cAMP-responsive-element-binding protein to activate the human thyroglobulin enhancer.
Berg V; Vassart G; Christophe D
Biochem J; 1997 Apr; 323 ( Pt 2)(Pt 2):349-57. PubMed ID: 9163323
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of human B cell activation by diterpine forskolin: interference with B cell growth factor-induced G1 to S transition of the B cell cycle.
Muraguchi A; Miyazaki K; Kehrl JH; Fauci AS
J Immunol; 1984 Sep; 133(3):1283-7. PubMed ID: 6086754
[TBL] [Abstract][Full Text] [Related]
49. Regulation of ornithine decarboxylase activity by IL-2 and cyclic AMP.
Farrar WL; Vinocour M; Cleveland JL; Harel-Bellan A
J Immunol; 1988 Aug; 141(3):967-71. PubMed ID: 2840461
[TBL] [Abstract][Full Text] [Related]
50. Distinct metabolism of cyclic adenosine monophosphate in regulatory and helper CD4+ T cells.
Bazhin AV; Kahnert S; Kimpfler S; Schadendorf D; Umansky V
Mol Immunol; 2010 Jan; 47(4):678-84. PubMed ID: 19939455
[TBL] [Abstract][Full Text] [Related]
51. Evidence that rapamycin inhibits interleukin-12-induced proliferation of activated T lymphocytes.
Bertagnolli MM; Yang L; Herrmann SH; Kirkman RL
Transplantation; 1994 Nov; 58(10):1091-6. PubMed ID: 7974715
[TBL] [Abstract][Full Text] [Related]
52. The cAMP-regulated enhancer-binding protein ATF-1 activates transcription in response to cAMP-dependent protein kinase A.
Rehfuss RP; Walton KM; Loriaux MM; Goodman RH
J Biol Chem; 1991 Oct; 266(28):18431-4. PubMed ID: 1655749
[TBL] [Abstract][Full Text] [Related]
53. Mitogen activation of human peripheral T lymphocytes induces the formation of new cyclic AMP response element-binding protein nuclear complexes.
Wollberg P; Söderqvist H; Nelson BD
J Biol Chem; 1994 Aug; 269(31):19719-24. PubMed ID: 8051051
[TBL] [Abstract][Full Text] [Related]
54. Role of tissue-specific transcription factor LFB3 in a cyclic AMP-responsive enhancer of the urokinase-type plasminogen activator gene in LLC-PK1 cells.
Soubt MK; Marksitzer R; Menoud PA; Nagamine Y
Mol Cell Biol; 1998 Aug; 18(8):4698-706. PubMed ID: 9671480
[TBL] [Abstract][Full Text] [Related]
55. Cyclin mRNA and protein expression in recombinant interleukin 2-stimulated cloned murine T lymphocytes.
Shipman PM; Sabath DE; Fischer AH; Comber PG; Sullivan K; Tan EM; Prystowsky MB
J Cell Biochem; 1988 Nov; 38(3):189-98. PubMed ID: 2906640
[TBL] [Abstract][Full Text] [Related]
56. Platelet-activating factor mediates MMP-2 expression and activation via phosphorylation of cAMP-response element-binding protein and contributes to melanoma metastasis.
Melnikova VO; Mourad-Zeidan AA; Lev DC; Bar-Eli M
J Biol Chem; 2006 Feb; 281(5):2911-22. PubMed ID: 16306050
[TBL] [Abstract][Full Text] [Related]
57. Cyclosporine, FK506, and rapamycin. Some effects on early activation events in serum-free, mitogen-stimulated mouse spleen cells.
Metcalfe SM; Richards FM
Transplantation; 1990 Apr; 49(4):798-802. PubMed ID: 1691537
[TBL] [Abstract][Full Text] [Related]
58. DNA modifications repaired by base excision repair are epigenetic.
Moore SP; Toomire KJ; Strauss PR
DNA Repair (Amst); 2013 Dec; 12(12):1152-8. PubMed ID: 24216087
[TBL] [Abstract][Full Text] [Related]
59. CD2 signalling induces phosphorylation of CREB in primary lymphocytes.
Guyot DJ; Newbound GC; Lairmore MD
Immunology; 1998 Dec; 95(4):544-52. PubMed ID: 9893043
[TBL] [Abstract][Full Text] [Related]
60. Abnormality of Oct-1 DNA binding in T cells from Sjögren's syndrome patients.
Flescher E; Vela-Roch N; Ogawa N; Nakabayashi T; Escalante A; Anaya JM; Dang H; Talal N
Eur J Immunol; 1996 Sep; 26(9):2006-11. PubMed ID: 8814238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
